These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3071345)

  • 21. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
    Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow changes in patients with refractory aplastic anemia treated by recombinant GM-CSF.
    Naeim F; Champlin R; Nimer S
    Hematol Pathol; 1990; 4(2):79-85. PubMed ID: 2197266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
    Nienhuis AW; Donahue RE; Karlsson S; Clark SC; Agricola B; Antinoff N; Pierce JE; Turner P; Anderson WF; Nathan DG
    J Clin Invest; 1987 Aug; 80(2):573-7. PubMed ID: 3301903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy for acute leukemias at higher age or after relapse.
    Büchner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig WD
    Haematol Blood Transfus; 1990; 33():724-31. PubMed ID: 2182462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to immortalise human AML cells using human recombinant GMCSF in vitro and in vivo.
    Clutterbuck R; Newman A; Powles R; Kwong Y; Millar J; Shepherd V; Smith C
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():40-1. PubMed ID: 2697435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.
    Estey EH; Dixon D; Kantarjian HM; Keating MJ; McCredie K; Bodey GP; Kurzrock R; Talpaz M; Freireich EJ; Deisseroth AB
    Blood; 1990 May; 75(9):1766-9. PubMed ID: 2184901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
    Linch DC; Devereux S; Addison IE
    Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
    Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
    Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
    Hoelzer D; Ganser A; Greher J; Völkers B; Walther F
    Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
    Grigg A; Begley CG; Juttner CA; Szer J; To LB; Maher D; McGrath KM; Morstyn G; Fox RM; Sheridan WP
    Bone Marrow Transplant; 1993; 11 Suppl 2():23-9. PubMed ID: 8334435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.